{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:47Z","timestamp":1787671727407,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1989,10,1]],"date-time":"1989-10-01T00:00:00Z","timestamp":623203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1989,10]]},"DOI":"10.1007\/bf02110252","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T20:38:56Z","timestamp":1126643936000},"page":"69-75","source":"Crossref","is-referenced-by-count":3,"title":["Eflornithine"],"prefix":"10.1007","volume":"11","author":[{"given":"I.","family":"Van Bogaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Haemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02110252_CR1","first-page":"53","volume":"4","author":"JR Brown","year":"1983","unstructured":"Brown JR. Human trypanosomiasis and their treatment. Pharm Int 1983;4:53\u20137.","journal-title":"Pharm Int"},{"key":"BF02110252_CR2","unstructured":"UNDP, World Bank, WHO. Special programme for research and training in tropical diseases. Sixth programme report, 1983: chapter 5."},{"key":"BF02110252_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-6851(87)90113-7","volume":"24","author":"GB Henderson","year":"1987","unstructured":"Henderson GB, Fairlamb AH, Cerami A. Trypanothione dependent peroxide metabolism inCrithidia fasciculata andTrypanosoma brucei. Mol Biochem Parasitol 1987; 24:39\u201345.","journal-title":"Mol Biochem Parasitol"},{"key":"BF02110252_CR4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.3883489","volume":"227","author":"AH Fairlamb","year":"1985","unstructured":"Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A. Trypanothione: a novel bis (glutathionyl) spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985;227:1485\u20137.","journal-title":"Science"},{"key":"BF02110252_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0166-6851(87)90105-8","volume":"24","author":"AH Fairlamb","year":"1987","unstructured":"Fairlamb AH, Henderson GB, Bacchi CJ, Cerami A.In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms ofTrypanosoma brucei. Mol Biochem Parasitol 1987;24:185\u201391.","journal-title":"Mol Biochem Parasitol"},{"key":"BF02110252_CR6","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/bi00385a011","volume":"26","author":"GB Henderson","year":"1987","unstructured":"Henderson GB, Fairlamb AH, Ulrich P, Cerami A. Substrate specifity of the flavoprotein trypanothione disulfide reductase fromCrithidia fasciculata. Biochemistry 1987;26:3023\u20137.","journal-title":"Biochemistry"},{"key":"BF02110252_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0166-6851(86)90130-1","volume":"21","author":"AH Fairlamb","year":"1986","unstructured":"Fairlamb AH, Henderson GB, Cerami A. The biosynthesis of trypanothione and N1-glutathionylspermidine inCrithidia fasciculata. Mol Biochem Parasitol 1986;21: 247\u201357.","journal-title":"Mol Biochem Parasitol"},{"key":"BF02110252_CR8","first-page":"398","volume":"35","author":"Y Furet","year":"1987","unstructured":"Furet Y, Duong TH, Combescot C, Breteau M. Une mol\u00e9cule nouvelle en th\u00e9rapeutique antiparasitaire: l'\u03b1-difluorom\u00e9thylornithine. Pathol Biol 1987;35:398\u2013404.","journal-title":"Pathol Biol"},{"key":"BF02110252_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.1987.36.46","volume":"36","author":"CJ Bacchi","year":"1987","unstructured":"Bacchi CJ, Nathan HC, Clarkson AB, et al. Effects of the ornithine decarboxylase inhibitorsDl-\u03b1-difluoromethylornithine and\u03b1-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin againstTrypanosoma brucei brucei central nervous system models. Am J Trop Med Hyg 1987;36:46\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02110252_CR10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0020-711X(85)90238-1","volume":"17","author":"MA Grillo","year":"1985","unstructured":"Grillo MA. Metabolism and function of polyamines. Int J Biochem 1985;17:943\u20138.","journal-title":"Int J Biochem"},{"key":"BF02110252_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00296251","volume":"19","author":"JC Romyn","year":"1987","unstructured":"Romyn JC, Verkoelen CF, Splinter TAW. Problems of pharmacokinetic studies on\u03b1-difluoromethylornithine in mice. Cancer Chemother Pharmacol 1987;19:30\u20134.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02110252_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1550-7408.1981.tb02798.x","volume":"28","author":"CJ Bacchi","year":"1981","unstructured":"Bacchi CJ. Content, synthesis and function of polyamines in trypanosomatids: relationship to chemotherapy. J Protozool 1981;28:20\u20137.","journal-title":"J Protozool"},{"key":"BF02110252_CR13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4269\/ajtmh.1986.35.1153","volume":"35","author":"PP McCann","year":"1986","unstructured":"McCann PP, Bacchi CJ, Clarkson AB. Inhibition of polyamine biosynthesis by\u03b1-difluoromethylornithine in African trypanosomes andPneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects. Am J Trop Med Hyg 1986;35:1153\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02110252_CR14","doi-asserted-by":"crossref","first-page":"13216","DOI":"10.1016\/S0021-9258(18)69293-2","volume":"261","author":"JG Kelland","year":"1986","unstructured":"Kelland JG, Arnold LD, Palcic MM, Pickard MA, Vederas JC. Analogs of diaminopimelic acid as inhibitors of meso-diaminopimelate decarboxylase fromBacillus sphaericus and wheat germ. J Biol Chem 1986;261:13216\u201323.","journal-title":"J Biol Chem"},{"key":"BF02110252_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1550-7408.1986.tb05599.x","volume":"33","author":"BF Giffin","year":"1986","unstructured":"Giffin BF, McCann PP, Bitonti AJ, Bacchi CJ. Polyamine depletion following exposure toDl-\u03b1-difluoromethylornithine bothin vivo andin vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain ofTrypanosoma brucei brucei. J Protozool 1986;33:238\u201343.","journal-title":"J Protozool"},{"key":"BF02110252_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-2952(86)90534-4","volume":"35","author":"AJ Bitonti","year":"1986","unstructured":"Bitonti AJ, McCann PP, Sjoerdsma A. Necessity of antibody response in the treatment of African trypanosomiasis with\u03b1-difluoromethylornithine. Biochem Pharmacol 1986;35:331\u20134.","journal-title":"Biochem Pharmacol"},{"key":"BF02110252_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(87)90107-0","volume":"82","author":"H Taelman","year":"1987","unstructured":"Taelman H, Schechter PJ, Marcelis L, et al. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Am J Med 1987;82:607\u201313.","journal-title":"Am J Med"},{"key":"BF02110252_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/bj2500295","volume":"250","author":"AJ Bitonti","year":"1988","unstructured":"Bitonti AJ, Cross-Doersen DE, McCann PP. Effects of\u03b1-difluoromethylornithine on protein synthesis and synthesis of the variant-specific glycoprotein (VSG) inTrypanosoma brucei brucei. Biochem J 1988;250:295\u20138.","journal-title":"Biochem J"},{"key":"BF02110252_CR19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1128\/IAI.55.10.2461-2464.1987","volume":"55","author":"F Kierszenbaum","year":"1987","unstructured":"Kierszenbaum F, Wirth JJ, McCann PP, Sjoerdsma A. Impairment of macrophage function by inhibitors of ornithine decarboxylase activity. Infect Immun 1987;55: 2461\u20134.","journal-title":"Infect Immun"},{"key":"BF02110252_CR20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0006-2952(86)90539-3","volume":"35","author":"AJ Bitonti","year":"1986","unstructured":"Bitonti AJ, Bacchi CJ, McCann PP, Sjoerdsma A. Uptake of\u03b1-difluoromethylornithine byTrypanosoma brucei brucei. Biochem Pharmacol 1986;35:351\u20134.","journal-title":"Biochem Pharmacol"},{"key":"BF02110252_CR21","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1073\/pnas.84.12.4278","volume":"84","author":"F Kierszenbaum","year":"1987","unstructured":"Kierszenbaum F, Wirth JJ, McCann PP, Sjoerdsma A. Arginine decarboxylase inhibitors reduce the capacity ofTrypanosoma cruzi to infect and multiply in mammalian host cells. Proc Natl Acad Sci USA. 1987;84:4278\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02110252_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bj2420069","volume":"242","author":"AJ Bitonti","year":"1987","unstructured":"Bitonti AJ, Casara PJ, McCann PP, Bey P. Catalytic irreversible inhibition of bacterial and plant arginine decarboxylase activities by novel substrate and product analogues. Biochem J 1987;242:69\u201374.","journal-title":"Biochem J"},{"key":"BF02110252_CR23","doi-asserted-by":"crossref","first-page":"C212","DOI":"10.1152\/ajpcell.1982.243.5.C212","volume":"243","author":"AE Pegg","year":"1982","unstructured":"Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212\u201322.","journal-title":"Am J Physiol"},{"key":"BF02110252_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/clpt.1981.150","volume":"30","author":"K Haegele","year":"1981","unstructured":"Haegele K, Alken RG, Grove J, Schechter PJ, Koch-Weser J. Kinetics of\u03b1-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase. Clin Pharm Ther 1981;30:210\u20137.","journal-title":"Clin Pharm Ther"},{"key":"BF02110252_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1984.33","volume":"35","author":"A Sjoerdsma","year":"1984","unstructured":"Sjoerdsma A, Schechter PJ. Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharmacol Ther 1984;35:287\u201398.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02110252_CR26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/0035-9203(85)90195-6","volume":"79","author":"S Nieuwenhove Van","year":"1985","unstructured":"Van Nieuwenhove S, Schechter PJ, Declerq J, Bone G, Burke J, Sjoerdsma A. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO, an inhibitor of ornithine decarboxylase, first field trial. Trans R Soc Trop Med Hyg 1985;79:692\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"BF02110252_CR27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0035-9203(87)90465-2","volume":"81","author":"PP McCann","year":"1987","unstructured":"McCann PP, Bitonti AJ, Bacchi CJ, Clarkson AB Jr. Use of difluoromethylornithine (DFMO, eflornithine) for late stage African trypanosomiasis. Trans R Soc Trop Med Hyg 1987;81:701\u20132.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"BF02110252_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archpedi.1988.02150020126047","volume":"142","author":"AM Petru","year":"1988","unstructured":"Petru AM, Azimi PH, Cummins SK, Sjoerdsma A. African sleeping sickness in the United States. Successful treatment with eflornithine. Am J Dis Child 1988;142:224\u20138.","journal-title":"Am J Dis Child"},{"key":"BF02110252_CR29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0140-6736(87)91131-7","volume":"2","author":"J Pepin","year":"1987","unstructured":"Pepin J, Milord F, Guern C, Schechter PJ. Difluoromethylornithine for arsenoresistantTrypanosoma brucei gambiense sleeping sickness. Lancet 1987;2:1431\u20133.","journal-title":"Lancet"},{"key":"BF02110252_CR30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4269\/ajtmh.1987.37.525","volume":"37","author":"F Doua","year":"1987","unstructured":"Doua F, Boa FY, Schechter PJ, et al. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Cote d'Ivoire. Am J Trop Med Hyg 1987;37:525\u201333.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02110252_CR31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0002-9343(87)90682-6","volume":"83","author":"G Scalabrino","year":"1987","unstructured":"Scalabrino G. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Am J Med 1987;83:1012\u20133.","journal-title":"Am J Med"},{"key":"BF02110252_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0006-2952(86)90509-5","volume":"35","author":"PS Mamont","year":"1986","unstructured":"Mamont PS, Danzin C, Kolb M, Gerhart F, Bey P, Sjoerdsma A. Marked and prolonged inhibition of mammalian ornithinedecarboxylasein vivo by esters of (E)-2-(fluoromethyl)-dehydro-ornithine. Biochem Pharmacol 1986;35:159\u201365.","journal-title":"Biochem Pharmacol"},{"key":"BF02110252_CR33","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/0006-2952(85)90648-3","volume":"34","author":"AJ Bitonti","year":"1985","unstructured":"Bitonti AJ, Bacchi C, McCann PP, Sjoerdsma A. Catalytic irreversible inhibition ofTrypanosoma brucei brucei ornithinedecarboxylase by substrate and product analogs and their effects on murine trypanosomiasis. Biochem Pharmacol 1985;34:1773\u20137.","journal-title":"Biochem Pharmacol"},{"key":"BF02110252_CR34","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1128\/AAC.31.9.1406","volume":"31","author":"CJ Bacchi","year":"1987","unstructured":"Bacchi CJ, Berens RZ, Nathan MC, et al. Synergism between 9-deazainosine andDl-\u03b1-difluoromethylornithine in treatment of experimental African trypanosomiasis. Antimicrob Agents Chemother 1987;31:1406\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02110252_CR35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4269\/ajtmh.1984.33.1073","volume":"33","author":"AB Clarkson","year":"1984","unstructured":"Clarkson AB, Bienen EJ, Baceti CJ, McCann PP, Nathan HC, Hutner SH, Sjoerdsma A. New drug combination for experimental late-stage African trypanosomiasis:Dl-\u03b1-difluoromethylornithine with suramin. Am J Trop Med Hyg 1984;33:1073\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"BF02110252_CR36","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1073\/pnas.80.18.5729","volume":"80","author":"AB Clarkson","year":"1983","unstructured":"Clarkson AB, Bacchi CJ, Mellow GH, Nathan MC, McCann PP, Sjoerdsma A. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis. Proc Natl Acad Sci USA 1983;80:5729\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02110252_CR37","first-page":"933","volume":"47","author":"PS Sunkara","year":"1987","unstructured":"Sunkara PS, Rosenberger AL. Antimetastatic activity ofDl-\u03b1-difluoromethylornithine, an inhibition of polyamine biosynthesis, in mice. Cancer Res 1987;47:933\u20135.","journal-title":"Cancer Res"},{"key":"BF02110252_CR38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-4894(87)90148-2","volume":"64","author":"AJ Bitonti","year":"1987","unstructured":"Bitonti AJ, McCann PP, Sjoerdsma A.Plasmodium falciparum andPlasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. Exp Parasitol 1987;64:237\u201343.","journal-title":"Exp Parasitol"},{"key":"BF02110252_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00431009","volume":"98","author":"MA Pfaller","year":"1987","unstructured":"Pfaller MA, Gerarden T, Riley J. Growth inhibition of pathogenic yeast isolates by\u03b1-difluoromethylornithine: an inhibition of ornithine decarboxylase. Mycopathologia 1987;98:3\u20138.","journal-title":"Mycopathologia"},{"key":"BF02110252_CR40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0169-4758(87)90116-5","volume":"3","author":"WT Hughes","year":"1987","unstructured":"Hughes WT. Treatment and prophylaxis forPneumocystis carinii pneumonia. Parasitol Today 1987;3:332\u20135.","journal-title":"Parasitol Today"}],"container-title":["Pharmaceutisch Weekblad"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02110252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02110252\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02110252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T11:18:51Z","timestamp":1626520731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02110252"}},"subtitle":["A new drug in the treatment of sleeping sickness"],"short-title":[],"issued":{"date-parts":[[1989,10]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,10]]}},"alternative-id":["BF02110252"],"URL":"https:\/\/doi.org\/10.1007\/bf02110252","relation":{},"ISSN":["0031-6911","1573-739X"],"issn-type":[{"value":"0031-6911","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,10]]}}}